141
Participants
Start Date
September 30, 2009
Primary Completion Date
March 11, 2011
Study Completion Date
March 11, 2011
hepatitis B vaccine
Primary vaccination series 20 µg/1.0 mL at baseline, month 1, month 6; followed by booster vaccinations 20 µg/1.0 mL
hepatitis B vaccine
Primary vaccination series 40 µg/2.0 mL at baseline, month 1, month 2, month 6; followed by booster vaccinations 20 µg/1.0 mL
Cangene Plasma Resources, Frederick, Frederick
Cangene Plasma Resources, Mid-Florida, Altamonte Springs
Lead Sponsor
Emergent BioSolutions
INDUSTRY